Skip to content

Differences in weight loss using a very low energy diet in obese people with and without diabetes.

In obese subjects with and without diabetes, examining the effect of a very low energy diet (VLED) on weight loss and differences in changes in cardiovascular risk, markers of oxidative stress and advanced glycation, and target organ function.

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000133437
Enrollment
80
Registered
2007-02-19
Start date
2007-04-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Obesity and type 2 diabetes increase the risk of heart, kidney and other disease. A process called oxidative stress is thought to be critical in triggering metabolic changes found in both obesity and diabetes, and thus is a major cause of developing complications from these conditions. The role of weight loss in reducing markers of oxidative stress has not been compared in obese people with and without diabetes. We predict that weight loss in obese patients with diabetes will reduce oxidative stress, and improve kidney and heart dysfunction, to a greater extent than in obese patients without diabetes.

Interventions

A very low energy diet (Optifast). This is a meal replacement diet involving three sachets daily plus one serve of vegetables or salad (600-800kcal/day) for 12 weeks (intensive phase). Subsequently patients are weaned over 8 weeks onto a calorie controlled CSIRO-type diet.

Sponsors

George Jerums
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

BMI 30 - 50 kg/m2, diabetes and no diabetes.

Exclusion criteria

Thiazolidinedione therapy, significant comorbidity, previously failed VLED or bariatric surgery.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026